Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2025-12-24 @ 10:51 PM
NCT ID:
NCT04499469
Eligibility Criteria:
Inclusion Criteria:
* Patients eligible for reduction rhinoseptoplasty who agreed to participate in the study and who did not meet the exclusion criteria
Exclusion Criteria:
* Absence of nasal obstruction;
* Previous nasosinusal surgery;
* Symmetrical or asymmetric insufficiency of the middle third that would justify the placement of middle third grafts for the treatment of these problems;
* Presence of nasal valve insufficiency as the only cause of nasal obstruction;
* Cranio-facial anomalies;
* Presence of nasosinusal tumors;
* Active acute rhinosinusitis;
* Patients undergoing treatment of other entities concomitant to rhinoseptoplasty such as: sinus inflammatory surgery, adenoid hypertrophy removal, septal perforation correction, otoplasty or blepharoplasty.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
14 Years
Maximum Age:
80 Years
Study:
NCT04499469
Study Brief:
Protocol Section:
NCT04499469